Literature DB >> 1993779

Reactivity of eccentric and concentric coronary stenoses in patients with chronic stable angina.

J C Kaski1, D Tousoulis, A W Haider, S Gavrielides, F Crea, A Maseri.   

Abstract

Dynamic coronary stenoses may be the cause of a variable angina threshold and rest angina in patients with chronic stable angina. It has been suggested that eccentric but not concentric coronary artery stenoses have the potential for dynamic changes of caliber in response to vasoactive stimuli. The vasomotor response of eccentric (asymmetric narrowing) and concentric (symmetric narrowing) coronary stenoses to ergonovine (20 micrograms intracoronary or 300 micrograms intravenous) and isosorbide dinitrate (1 mg intracoronary) was studied in 51 patients with chronic stable angina. Diameter of reference segments (angiographically normal segments proximal to the stenoses) and that of eccentric (n = 30) and concentric (n = 35) coronary stenoses that ranged from 50% to 90% luminal diameter reduction were measured by computerized quantitative angiography before and after ergonovine and isosorbide dinitrate. Ergonovine reduced stenosis diameter (by greater than or equal to 10%) in 80% of eccentric stenoses and 42% of concentric stenoses (p less than 0.05). Mean (+/- SEM) diameter reduction with ergonovine was 19 +/- 3% and 9.5 +/- 2% for eccentric and concentric stenoses, respectively (p less than 0.05). Isosorbide dinitrate increased coronary diameter (by greater than or equal to 10%) in 70% of eccentric and 43% of concentric stenoses (p less than 0.05). Mean diameter of eccentric stenoses increased from 1.15 +/- 0.05 to 1.35 +/- 0.06 mm after nitrate (18.6 +/- 2.5%), whereas diameter of concentric stenoses increased from 1.05 +/- 0.05 to 1.14 +/- 0.05 mm (10 +/- 2.5%) (p less than 0.05). Average dilation of reference segments with administration of isosorbide dinitrate and constriction with ergonovine were not significantly different in patients with concentric and eccentric stenoses.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993779     DOI: 10.1016/s0735-1097(10)80175-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

1.  Vasomotion and nitric oxide bioactivity in diseased coronary arteries.

Authors:  D Tousoulis; G J Davies; T Crake; P C Toutouzas
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

2.  Effects of L- and D-arginine on the basal tone of human diseased coronary arteries and their responses to substance P.

Authors:  D Tousoulis; C Tentolouris; T Crake; G Katsimaglis; C Stefanadis; P Toutouzas; G J Davies
Journal:  Heart       Date:  1999-05       Impact factor: 5.994

3.  Complex stenosis morphology and vasomotor responses to inhibition of nitric oxide synthesis.

Authors:  D Tousoulis; C Tentolouris; T Crake; G Goumas; C Stefanadis; P Toutouzas; G Davies
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

4.  Vasomotor effects of L- and D-arginine in stenotic atheromatous coronary plaque.

Authors:  D Tousoulis; G J Davies; C Tentolouris; G Goumas; C Stefanadis; P Toutouzas
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

Review 5.  Management of vasospastic angina--role of nicorandil.

Authors:  J C Kaski
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

6.  Early remodelling of coronary stenoses after thrombolytic treatment in patients with acute myocardial infarction.

Authors:  D Tousoulis; F Andreotti; D Hackett; A W Haider; A Maseri; G Davies
Journal:  Br Heart J       Date:  1995-09

7.  Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes.

Authors:  M K Sinha; D Roy; D C Gaze; P O Collinson; J C Kaski
Journal:  Emerg Med J       Date:  2004-01       Impact factor: 2.740

8.  Histological patterns of atherosclerotic plaques in unstable angina patients vary according to clinical presentation.

Authors:  J M Mann; J C Kaski; W I Pereira; S Arie; J A Ramires; F Pileggi
Journal:  Heart       Date:  1998-07       Impact factor: 5.994

9.  Reduction of daily life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factor.

Authors:  I Ikonomidis; F Andreotti; P Nihoyannopoulos
Journal:  Heart       Date:  2004-04       Impact factor: 5.994

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.